NVZMF:OTCMKTS
Novozymes A/S
၆၈.၀၀ US$
arrow_downward
-၁.၉၅%(-၁.၃၅) 1D
အောက် ၁၆, GMT-၄ ၁၀:၂၉:၀၂ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NVZMF...
Open
၆၈.၀၀ US$
High
၆၈.၀၀ US$
Low
၆၈.၀၀ US$
Mkt. cap
ဋေ ၁.၈၃ သ
Avg. vol.
၅၂၆.၀၀
Volume
၃၀.၀၀
52-wk high
၇၂.၉၈ US$
52-wk low
၅၂.၁၀ US$
Beta
၀.၈၂
Shares outstanding
၄၁.၄၆ ကုဋေ
No. of employees
၁ သောင်း
Open
၆၈.၀၀ US$
High
၆၈.၀၀ US$
Low
၆၈.၀၀ US$
Mkt. cap
ဋေ ၁.၈၃ သ
Avg. vol.
၅၂၆.၀၀
Volume
၃၀.၀၀
52-wk high
၇၂.၉၈ US$
52-wk low
၅၂.၁၀ US$
Beta
၀.၈၂
Shares outstanding
၄၁.၄၆ ကုဋေ
No. of employees
၁ သောင်း
News stories
From web sources and news partners
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၁ ရက်
Novonesis stock stands 1.27 percent below its 52-week high
Profile
Novonesis is a biotechnology company headquartered in Lyngby, Denmark. Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen.
The company develops enzymes, microbial cultures, and other biological products used in food and beverage production, household products, agriculture, and bioenergy.
The merger, first announced in December 2022, was the largest merger in history between two Danish companies. It would combine Novozymes' industrial-enzyme business with Chr. Hansen's microbial cultures and food-ingredient operations.
The company is publicly traded on Nasdaq Copenhagen and is part of the OMX Copenhagen 25 Index. The company's largest shareholder is Novo Holdings A/S, which is owned by the Novo Nordisk Foundation.
As of 2025, Novonesis has more than 11,000 employees and activities in over 45 countries. Wikipedia
About Novozymes A/S
CEOEster Baiget
Employees၁.၁၁ သောင်း
Founded၂၀၀၀
Headquarters-
SectorSpeciality chemicals
Websitenovonesis.com